Jean Stanton

Company: The Janssen Pharmaceutical Companies of Johnson & Johnson

Job title: Director Commercial Apheresis Operations

Bio:

A subject matter expert in regulatory compliance for the development of cell based products in the pharmaceutical industry. She spent more than half of her career working within a medical center’s collections/cell processing facility. Jean  has worked the last 10 years in a quality and compliance role within Janssen. She recently  assumed a role in Janssen Supply Chain, leading the technical relationship with apheresis and cell laboratories for CAR-T therapies, facilitating cell collection site certification activities related to apheresis and cell lab and building the internal support structures necessary to support commercial CAR-T manufacturing.

Seminars:

Panel Discussion: Considering Best Practice, Requirements and Approaches to Center Oversight and Audit to Assure Quality of Care and Materials 11:40 am

Download The Full Event Guide Read more

day: Day One

Panel Discussion: Can Cell Therapy Supply Chains be Standardized, and Developing Best Practice Guidelines for Efficiency at Scale and Better Patient Care 11:45 am

Download The Full Event Guide Read more

day: Day Two

Standardizing Cell Collection and Proposing ‘Best Practices’ in the Clinic 11:00 am - 11:30 am

Download The Full Event Guide Read more

day: Day One